Annual Current Liabilities
$331.77 M
+$193.08 M+139.21%
December 31, 2023
Summary
- As of February 7, 2025, CHRS annual total current liabilities is $331.77 million, with the most recent change of +$193.08 million (+139.21%) on December 31, 2023.
- During the last 3 years, CHRS annual current liabilities has risen by +$186.12 million (+127.78%).
- CHRS annual current liabilities is now at all-time high.
Performance
CHRS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$295.57 M
-$167.44 M-36.16%
September 30, 2024
Summary
- As of February 7, 2025, CHRS quarterly total current liabilities is $295.57 million, with the most recent change of -$167.44 million (-36.16%) on September 30, 2024.
- Over the past year, CHRS quarterly current liabilities has increased by +$55.91 million (+23.33%).
- CHRS quarterly current liabilities is now -45.09% below its all-time high of $538.30 million, reached on March 31, 2024.
Performance
CHRS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CHRS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +139.2% | +23.3% |
| 3 y3 years | +127.8% | +74.4% |
| 5 y5 years | +897.5% | +74.4% |
CHRS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +139.2% | -45.1% | +139.5% |
| 5 y | 5-year | at high | +188.6% | -45.1% | +157.1% |
| alltime | all time | at high | +2848.3% | -45.1% | +1231.5% |
Coherus BioSciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $295.57 M(-36.2%) |
| Jun 2024 | - | $463.00 M(-14.0%) |
| Mar 2024 | - | $538.30 M(+62.3%) |
| Dec 2023 | $331.77 M(+139.2%) | $331.77 M(+38.4%) |
| Sep 2023 | - | $239.66 M(+41.4%) |
| Jun 2023 | - | $169.44 M(+37.3%) |
| Mar 2023 | - | $123.41 M(-11.0%) |
| Dec 2022 | $138.69 M(-16.1%) | $138.69 M(-19.0%) |
| Sep 2022 | - | $171.32 M(+21.7%) |
| Jun 2022 | - | $140.75 M(-8.5%) |
| Mar 2022 | - | $153.75 M(-7.0%) |
| Dec 2021 | $165.33 M(+13.5%) | $165.33 M(-48.4%) |
| Sep 2021 | - | $320.35 M(+11.6%) |
| Jun 2021 | - | $287.05 M(+11.4%) |
| Mar 2021 | - | $257.60 M(+76.9%) |
| Dec 2020 | $145.65 M(+26.7%) | $145.65 M(+9.2%) |
| Sep 2020 | - | $133.43 M(+2.8%) |
| Jun 2020 | - | $129.76 M(+9.0%) |
| Mar 2020 | - | $119.01 M(+3.5%) |
| Dec 2019 | $114.97 M | $114.97 M(+39.0%) |
| Sep 2019 | - | $82.70 M(+35.1%) |
| Jun 2019 | - | $61.23 M(+47.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $41.41 M(+24.5%) |
| Dec 2018 | $33.26 M(+17.1%) | $33.26 M(+35.6%) |
| Sep 2018 | - | $24.54 M(+10.5%) |
| Jun 2018 | - | $22.20 M(-19.6%) |
| Mar 2018 | - | $27.62 M(-2.7%) |
| Dec 2017 | $28.39 M(-49.6%) | $28.39 M(-9.7%) |
| Sep 2017 | - | $31.43 M(-12.6%) |
| Jun 2017 | - | $35.95 M(-24.0%) |
| Mar 2017 | - | $47.30 M(-16.1%) |
| Dec 2016 | $56.38 M(-46.8%) | $56.38 M(-3.4%) |
| Sep 2016 | - | $58.39 M(-46.1%) |
| Jun 2016 | - | $108.28 M(+16.5%) |
| Mar 2016 | - | $92.92 M(-12.4%) |
| Dec 2015 | $106.02 M(+104.7%) | $106.02 M(+28.5%) |
| Sep 2015 | - | $82.52 M(+18.0%) |
| Jun 2015 | - | $69.95 M(+34.7%) |
| Mar 2015 | - | $51.91 M(+0.3%) |
| Dec 2014 | $51.78 M(-3.6%) | $51.78 M(+7.7%) |
| Sep 2014 | - | $48.08 M(+7.9%) |
| Jun 2014 | - | $44.56 M(-17.0%) |
| Dec 2013 | $53.70 M(+377.2%) | $53.70 M |
| Dec 2012 | $11.25 M | - |
FAQ
- What is Coherus BioSciences annual total current liabilities?
- What is the all time high annual current liabilities for Coherus BioSciences?
- What is Coherus BioSciences annual current liabilities year-on-year change?
- What is Coherus BioSciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Coherus BioSciences?
- What is Coherus BioSciences quarterly current liabilities year-on-year change?
What is Coherus BioSciences annual total current liabilities?
The current annual current liabilities of CHRS is $331.77 M
What is the all time high annual current liabilities for Coherus BioSciences?
Coherus BioSciences all-time high annual total current liabilities is $331.77 M
What is Coherus BioSciences annual current liabilities year-on-year change?
Over the past year, CHRS annual total current liabilities has changed by +$193.08 M (+139.21%)
What is Coherus BioSciences quarterly total current liabilities?
The current quarterly current liabilities of CHRS is $295.57 M
What is the all time high quarterly current liabilities for Coherus BioSciences?
Coherus BioSciences all-time high quarterly total current liabilities is $538.30 M
What is Coherus BioSciences quarterly current liabilities year-on-year change?
Over the past year, CHRS quarterly total current liabilities has changed by +$55.91 M (+23.33%)